Client Result
Orrick Advises Twist Bioscience on Upsized Public Offering of Common Stock
March.09.2022
Orrick advises Twist Bioscience on upsized public offering of common stock.
March.09.2022
Orrick advises Twist Bioscience on upsized public offering of common stock.
March.04.2022
March.18.2022
1 minute read | November.03.2022
April.26.2018
April.25.2018
April.17.2018
April.23.2018
April.11.2018
April.03.2018
April.13.2018